Particularly, previous investigations indicated that NOTCH1 and its target gene HES1 were markedly increased in GSCs, leading to tumor invasion and recurrence of GBM [67,68,69], and Notch1 overexpression was also associated with low overall survival [70]. The gene discussed is HES1; the disease is glioblastoma.